Glenmark Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '25
Dec '24
Sep '24
Jun '24
Mar '24
Total Qtr Revenue cr
3,267.89
3,418.68
3,473.21
3,275.68
3,836.12
Other Income Qtr Cr11.6831.1339.4231.49773.16
Operating Revenues Qtr3,256.213,387.553,433.803,244.193,062.95

*All values are in Cr.

Operating Expenses Qtr
2,695.18
2,787.32
2,831.88
2,655.97
2,558.61
Operating Profit Qtr
561.02
600.23
601.91
588.21
504.34
EBITDA Qtr Cr
199.89
631.36
641.33
619.70
855.10
Depreciation Qtr
125.20
122.74
120.28
117.79
151.34
Net Profit Qtr
4.65
347.96
354.21
340.27
-1,218.28
Basic EPS Qtr
0.16
12.33
12.55
12.06
-43.18
Open Demat Account
+91 -

Open Demat Account
+91 -